Carotid body tumor pathophysiology
Jump to navigation
Jump to search
|
Carotid body tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carotid body tumor pathophysiology On the Web |
|
American Roentgen Ray Society Images of Carotid body tumor pathophysiology |
|
Risk calculators and risk factors for Carotid body tumor pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Maria Fernanda Villarreal, M.D. [3]
Overview
The carotid body is an ellipsoid-like structure located in the adventitia or periadventitial tissue of the bifurcation of the common carotid artery. This organ is a chemo-receptor and its function is the monitoring of arterial blood oxygen and carbon dioxide levels. The exact pathogenesis of carotid body tumor is not fully understood. however, the overgrowth of chemoreceptor paraganglioma cells in the carotid body leads to the formation of carotid body tumor. Recent litreture has suggested the role of several germline mutations in the pathogenesis of this tumor. Also, the hyperplastic form of the tumor has been associated with conditions that causes chronic hypoxia.
Pathophysiology
Anatomy
- The carotid body is an ellipsoid-like structure located in the adventitia or periadventitial tissue of the bifurcation of the common carotid artery.[1]
- The normal carotid body weighs less than 15 mg and measures between 3 to 5 mm.
- This structure innervated by the hearing branch of the glossopharyngeal nerve, however, the carotid body is in close proximity of a majority of important nerves.
- The blood supply to the carotid body is provided by ascending pharyngeal artery, which is the branch of the external carotid artery.
Physiology
- The carotid body is a chemo-receptor and its function is the monitoring of arterial blood oxygen and carbon dioxide levels.[2][3]
- This organ is sensitive to the reduction of oxygen partial pressure in the blood which results in reflexive activation of the autonomic nervous system and the resultant increase in the
ventilation rate.
Pathogenesis
- Carotid body tumor is a neuroendocrine neoplasm originating from carotid body.[4]
- Carotid body is a component of the autonomic nervous system derived from neural crest cells of the embryonic third branchial arch.[1]
- The overgrowth of chemoreceptor paraganglioma cells in the carotid body leads to the formation of carotid body tumor.
- Carotid body tumors are normally located in the medial aspect adventitia of the carotid bifurcation.
- Carotid body tumor occurs sporadicly in 85% to 90% of the cases.[1][5]
- Recent litreture has suggested the role of several germline mutations in the pathogenesis of this tumor.[6]
- It has been explained that the hyperplastic form of the tumor is associated with chronic hypoxia due to such as:[1][7]
- The tumor may be bilateral in fewer than 5% of the sporadic cases.
- The tumor may be familial in the rest 10% to 15%.
Genetics
- The familial form of the tumor is associated with a mutation in a gene located on 11q23.[8]
- The disease inheritance is through autosomal dominance.[9]
- The following genes has been linked to an increased incidence of paraganglioma including carotid body tumor:[10][6]
- Succinate dehydrogenase (SDH) complex subunits B, C, and D.
- RET
- Von Hippel-Lindau (VHL)
- Neurofibromatosis type I (NF1)
Associated Conditions
Conditions associated with carotid body tumor include:[6]
- Von Hippel-Lindau syndrome
- Neurofibromatosis type I (von Recklinghausen disease)
- MEN 2A
- MEN 2B
- Carney's triad which consists of:[11]
- Gastric leiomyosarcoma
- Pulmonary chondroma
- Extraadrenal paraganglioma
Gross Pathology
|Characteristic findings of carotid body tumor, include:[6]
- Well-circumscribed with psudocapsule
- The size of the tumor varies greatly and it may be as large as 10 cm
- The cutting surface is solid with a smooth, rubbery texture
|
Microscopic Pathology
- On microscopic histopathological analysis, carotid body tumor composed of:
- The chief or paraganglionic cells composing the predominant part of the tumor and contain eosinophilic granular materials and oval or round nuclei.[12]
- The supporting or sustentacular cells responsible for the chemoreceptor activity of the carotid body
- The characteristic finding of this tumor is:
- Chief cells Arranged in distinctive pattern called cell balls (zellballen)
- Separated by fibrovascular stroma and surrounded by sustentacular cells
- The cytoplasm is pale and diffuse with occasional presence of the eosinophilic granules.[13]
- The nuclei are round to spindle shape.
- The tumor is highly vascular.
- Although there is no well-accepted histologic criteria for the diagnosis of malignant tumors, worrisome histologic features include:[6]
|
Immunohistochemistry
- Type 1 cells, sustentacular cells, are stained by:[14]
- Type 2 cells, cheif cell, are stained by:
- Chromogranins
- Synaptophysisn
- The tumor cells may also be positive for other markers of neuroendocrine differentiation such as:[6]
References
- ↑ 1.0 1.1 1.2 1.3 Burgess, Alfred; Calderon, Moises; Jafif-Cojab, Marcos; Jorge, Diego; Balanza, Ricardo (2017). "Bilateral carotid body tumor resection in a female patient". International Journal of Surgery Case Reports. 41: 387–391. doi:10.1016/j.ijscr.2017.11.019. ISSN 2210-2612.
- ↑ Robertson, David (2012). Primer on the autonomic nervous system. London: Elsevier. ISBN 978-0-12-386525-0.
- ↑ Zufall, Frank (2016). Chemosensory transduction : the detection of odors, tastes, and other chemostimuli. London, UK: Academic Press is an imprint of Elsevier. ISBN 978-0-12-801694-7.
- ↑ Boedeker CC, Ridder GJ, Schipper J (2005). "Paragangliomas of the head and neck: diagnosis and treatment". Fam. Cancer. 4 (1): 55–9. doi:10.1007/s10689-004-2154-z. PMID 15883711.
- ↑ Ridge, Brian A.; Brewster, David C.; Darling, R. Clement; Cambria, Richard P.; LaMuraglia, Glenn M.; Abbott, William M. (1993). "Familial Carotid Body Tumors: Incidence and Implications". Annals of Vascular Surgery. 7 (2): 190–194. doi:10.1007/BF02001015. ISSN 0890-5096.
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 Wieneke, Jacqueline A.; Smith, Alice (2009). "Paraganglioma: Carotid Body Tumor". Head and Neck Pathology. 3 (4): 303–306. doi:10.1007/s12105-009-0130-5. ISSN 1936-055X.
- ↑ Sajid, M.S.; Hamilton, G.; Baker, D.M. (2007). "A Multicenter Review of Carotid Body Tumour Management". European Journal of Vascular and Endovascular Surgery. 34 (2): 127–130. doi:10.1016/j.ejvs.2007.01.015. ISSN 1078-5884.
- ↑ Fennessy, B. G.; Kozakewich, H. P. W.; Silvera, M.; Frerichs, K.; Lillhei, C. W.; Poe, D.; Rahbar, R. (2009). "The presentation and management of multiple paraganglioma in head and neck". Irish Journal of Medical Science. 180 (3): 757–760. doi:10.1007/s11845-009-0338-0. ISSN 0021-1265.
- ↑ Young AL, Baysal BE, Deb A, Young WF (September 2002). "Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene". J. Clin. Endocrinol. Metab. 87 (9): 4101–5. doi:10.1210/jc.2002-020312. PMID 12213855.
- ↑ Davila, Victor J.; Chang, James M.; Stone, William M.; Fowl, Richard J.; Bower, Thomas C.; Hinni, Michael L.; Money, Samuel R. (2016). "Current surgical management of carotid body tumors". Journal of Vascular Surgery. 64 (6): 1703–1710. doi:10.1016/j.jvs.2016.05.076. ISSN 0741-5214.
- ↑ Carney JA, Sheps SG, Go VL, Gordon H (June 1977). "The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma". N. Engl. J. Med. 296 (26): 1517–8. doi:10.1056/NEJM197706302962609. PMID 865533.
- ↑ Patetsios, Peter; Gable, Dennis R.; Garrett, Wilson V.; Lamont, Jeffrey P.; Kuhn, Joseph A.; Shutze, William P.; Kourlis, Harry; Grimsley, Bradley; Pearl, Gregory J.; Smith, Bertram L.; Talkington, C.M.; Thompson, Jesse E. (2002). "Management of Carotid Body Paragangliomas and Review of a 30-year Experience". Annals of Vascular Surgery. 16 (3): 331–338. doi:10.1007/s10016-001-0106-8. ISSN 0890-5096.
- ↑ Bibbo, Marluce (2008). Comprehensive cytopathology. Philadelphia, PA: Saunders/Elsevier. ISBN 978-1-4160-4208-2.
- ↑ Schmid KW, Schröder S, Dockhorn-Dworniczak B, Kirchmair R, Tötsch M, Böcker W, Fischer-Colbrie R (April 1994). "Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretogranin II in extra-adrenal paragangliomas". Mod. Pathol. 7 (3): 347–53. PMID 8058707.